Journal of Diabesity

A peer-reviewed open-access journal dedicated to diabetes and obesity research.

JoDiabesity Journal of Diabesity Medium

tirzepatide for heart failure and weight loss

Journal of Diabesity

Welcome to the Journal of Diabesity, a peer-reviewed open-access medical journal dedicated to advancing research in diabetes and obesity.

Professional Medical Journal

Advancing Research in Diabetes and Obesity

A healthcare professional is standing beside a patient who is lying in a hospital bed. The professional is wearing a surgical cap, mask, and white coat, while holding a clipboard. The patient is covered with a blue sheet and also wears a mask. Medical equipment is visible in the background.

Submit Your Research

Join us in advancing medical knowledge by submitting your research to the Journal of Diabesity. Share your findings today.

journal of Diabesity volume 1 issue 1

Volume 1, Issue 1

jod volume 1 issue 2

Volume 1, Issue 2

Diabesity Journal Insights | Patient-Reported Changes in Weight, Appetite, and Lifestyle During Evolocumab Therapy

repatha evolocumab weight changes

Patient-Reported Changes in Weight, Appetite, and Lifestyle During Evolocumab Therapy

In an exploratory survey of evolocumab users, 81% reported weight gain—often within weeks of starting therapy and independent of lifestyle changes. These findings suggest a potential patient-perceived metabolic effect that warrants prospective investigation.

Diabesity Journal Insights | Suspected Optic Nerve Dysfunction Associated with Semaglutide in a Non-Diabetic Obese Patient: A Case Report

optic nerve dysfunction with semaglutide therapy

Suspected Optic Nerve Dysfunction Associated with Semaglutide in a Non-Diabetic Obese Patient: A Case Report

As the use of semaglutide expands beyond diabetes into obesity management, rare yet vision-threatening neuro-ophthalmic complications may be emerging in unexpected patient populations.

Diabesity Journal Insights | Synergistic Metabolic Effects of Dapagliflozin Added to Pioglitazone in Type 2 Diabetes: a randomized comparative study

pioglitazone added to dapagliflozin diabetes

Synergistic Metabolic Effects of Dapagliflozin Added to Pioglitazone in Type 2 Diabetes: a randomized comparative study

Combining pioglitazone with dapagliflozin enhances glycemic control, improves insulin sensitivity, and demonstrates better tolerability.

Diabesity Journal Insights | Case Report of Hepatic Granuloma Associated with Semaglutide

Semaglutide-Associated Severe Gastrointestinal Intolerance and Hepatic Granulomas: A Case Report

An unusual case report describing liver-related side effects of Semaglutide

Diabesity Journal Insights | Nurtec, CGRP-antagonists, and Weight Gain

Weight Changes in Patients Using Nurtec ODT: Patient-Reported Outcomes from a Real-World Survey

Obesity and migraine commonly co-exist. How do the latest migraine medications affect your body weight?